42 related articles for article (PubMed ID: 38485187)
21. An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.
Kennedy AD; Solga MD; Schuman TA; Chi AW; Lindorfer MA; Sutherland WM; Foley PL; Taylor RP
Blood; 2003 Feb; 101(3):1071-9. PubMed ID: 12393727
[TBL] [Abstract][Full Text] [Related]
22. CABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous sheath protein involved in capacitation.
Naaby-Hansen S; Mandal A; Wolkowicz MJ; Sen B; Westbrook VA; Shetty J; Coonrod SA; Klotz KL; Kim YH; Bush LA; Flickinger CJ; Herr JC
Dev Biol; 2002 Feb; 242(2):236-54. PubMed ID: 11820818
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies to oncoproteins.
Chang JH; Sutherland WM; Parsons SJ
Methods Enzymol; 1995; 254():430-45. PubMed ID: 8531704
[No Abstract] [Full Text] [Related]
24. The human keratinocyte two-dimensional gel protein database (update 1992): towards an integrated approach to the study of cell proliferation, differentiation and skin diseases.
Celis JE; Rasmussen HH; Madsen P; Leffers H; Honoré B; Dejgaard K; Gesser B; Olsen E; Gromov P; Hoffmann HJ
Electrophoresis; 1992 Dec; 13(12):893-959. PubMed ID: 1286666
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing the choice of monoclonal antibodies for antibody-drug conjugates.
Hasan MM; Laws M; Jin P; Rahman KM
Drug Discov Today; 2022 Jan; 27(1):354-361. PubMed ID: 34597756
[TBL] [Abstract][Full Text] [Related]
26. Antibody-drug conjugates in cancer therapy.
Sievers EL; Senter PD
Annu Rev Med; 2013; 64():15-29. PubMed ID: 23043493
[TBL] [Abstract][Full Text] [Related]
27. [Design of next generation antibody drug conjugates].
Zhu GD; Fu YX
Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
[TBL] [Abstract][Full Text] [Related]
28. Antibody-targeted drugs and drug resistance--challenges and solutions.
Shefet-Carasso L; Benhar I
Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
[TBL] [Abstract][Full Text] [Related]
29. Cell killing by antibody-drug conjugates.
Kovtun YV; Goldmacher VS
Cancer Lett; 2007 Oct; 255(2):232-40. PubMed ID: 17553616
[TBL] [Abstract][Full Text] [Related]
30. Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Staudacher AH; Brown MP
Br J Cancer; 2017 Dec; 117(12):1736-1742. PubMed ID: 29065110
[TBL] [Abstract][Full Text] [Related]
31. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.
Ceci C; Lacal PM; Graziani G
Pharmacol Ther; 2022 Aug; 236():108106. PubMed ID: 34990642
[TBL] [Abstract][Full Text] [Related]
32. Endoglin-targeted cancer therapy.
Seon BK; Haba A; Matsuno F; Takahashi N; Tsujie M; She X; Harada N; Uneda S; Tsujie T; Toi H; Tsai H; Haruta Y
Curr Drug Deliv; 2011 Jan; 8(1):135-43. PubMed ID: 21034418
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment.
Deng S; Lin Z; Li W
Curr Med Chem; 2017; 24(23):2505-2527. PubMed ID: 28554322
[TBL] [Abstract][Full Text] [Related]
34. Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer.
Xu Q; Jia C; Ou Y; Zeng C; Jia Y
Front Oncol; 2024; 14():1371421. PubMed ID: 38511141
[TBL] [Abstract][Full Text] [Related]
35. Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates.
Mandal A; Shetty J; Tran CA; Olson WC; Mandal M; Ban B; Pires ES; Adair SJ; Bauer TW; Slingluff CL; Herr JC
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485187
[TBL] [Abstract][Full Text] [Related]
36. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
[TBL] [Abstract][Full Text] [Related]
37. Antibody-Drug Conjugates Targeting Tumor-Specific Mucin Glycoepitopes.
Brassard J; Hughes MR; Roskelley CD; McNagny KM
Front Biosci (Landmark Ed); 2022 Nov; 27(11):301. PubMed ID: 36472102
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]